Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Calcitriol in Oral Cancer
NCT00953849Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2009
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib, calcitriol in oral squamous cell carcinoma (OSCC), sponsored by VA Office of Research & Development. Started Nov 2009; status: completed.
02
Drugs
celecoxibcalcitriol
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT00953849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953849.